19:
of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. This directive of the
31:
The
Directive says that Member States shall take all appropriate measures to ensure that the applications for marketing authorization, are submitted by the applicants in accordance with the guidelines of the Directive.
118:
108:
103:
98:
66:
83:
71:
28:
by introducing the mutual recognition, by Member States, of their respective national marketing authorisations.
113:
61:
51:
46:
56:
21:
92:
24:
sought to bring the benefits of innovative pharmaceuticals to patients across
41:
25:
8:
84:Council Directive 75/318/EEC of 20 May 1975
119:1975 in the European Economic Community
7:
109:European Union directives by number
14:
67:Regulation of therapeutic goods
1:
135:
104:European Union directives
72:European Medicines Agency
99:Pharmaceuticals policy
62:Directive 2001/83/EC
52:Directive 65/65/EEC1
47:Directive 75/319/EEC
17:Directive 75/318/EEC
57:Directive 93/41/EEC
126:
134:
133:
129:
128:
127:
125:
124:
123:
89:
88:
80:
38:
12:
11:
5:
132:
130:
122:
121:
116:
111:
106:
101:
91:
90:
87:
86:
79:
76:
75:
74:
69:
64:
59:
54:
49:
44:
37:
34:
22:European Union
13:
10:
9:
6:
4:
3:
2:
131:
120:
117:
115:
112:
110:
107:
105:
102:
100:
97:
96:
94:
85:
82:
81:
77:
73:
70:
68:
65:
63:
60:
58:
55:
53:
50:
48:
45:
43:
40:
39:
35:
33:
29:
27:
23:
18:
30:
16:
15:
114:1975 in law
93:Categories
78:References
42:EudraLex
36:See also
26:Europe
95::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.